Tissue-based genomic classifier tests, developed to improve prostate cancer risk assessment and treatment recommendations, ...

Genomic classifier (GC) tests do not appear to consistently influence risk classification or treatment decisions for patients ...

Three former members of the Indiana men's basketball team have filed a lawsuit against the school, claiming their doctor at ...

Learn how an enlarged prostate and Parkinsonism can overlap, impact daily life, and be managed effectively for better health.

Two brothers have described being told they had cancer within weeks of each other. Keith Powell's prostate was removed just ...

OncoAssure Ltd, an Irish medical diagnostic company, announced the publication of new data in the journal BJUI Compass that ...

In 2024, Feng received the “Mentorship Award” from ASTRO. In December, the American Society for Clinical Oncology (ASCO) ...

Physicians in the field of urology have advised men, particularly those of African descent to stop attributing the cause of ...

High intensity focused ultrasound (HIFU) is a novel prostate cancer treatment that minimizes side effect while destroying ...

For patients with localized prostate cancer (PCa), tissue-based genomic classifiers (GCs) do not consistently influence risk ...

(HealthDay News) — There is an increase in psychotropic medication use and mental health service use around the time of prostate cancer diagnosis, according to a study published online July 3 in ...

CHICAGO, IL / ACCESS Newswire / January 22, 2025 / ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a diversified, ...